跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CABAZITAXEL TEVAGEN 10 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CABAZITAXEL TEVAGEN 10 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Approved
STANDARD
CABAZITAXEL TEVAGEN 10 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Teva B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 17, 2022
Approval ID
97131b7c640f6dd1
Company
Teva B.V.
Type
Standard
Approval Details
Approval Id
97131b7c640f6dd1
Drug Cima Aemps Name
CABAZITAXEL TEVAGEN 10 MG/ML CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Register Number
88035
Holder Company Name
Teva B.V.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-pharma-b-v
Authorization Date
2022-08-17
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
10 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Teva B.V.
Company Detail Path
/organization/teva-pharma-b-v
Company Information
Pharmaceutical Company Name
Teva Pharma B.V.
Country Name
Netherlands
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Website
http://www.tevapharm.com
Active Ingredients
CABAZITAXEL 2-PROPANOL SOLVATO
64,3 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 17, 2022
Approval ID
97131b7c640f6dd1
Type
Standard
Back to CIMA-AEMPS Approvals